Welcome to our dedicated page for Concentrix SEC filings (Ticker: CNXC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Concentrix Corporation filings document the company’s results, governance, financing arrangements and capital structure as a public technology and services issuer. Form 8-K reports include quarterly and annual operating results, dividend and share repurchase information, material agreements, debt offerings, note redemptions and amendments to its accounts receivable securitization facility through Concentrix Receivables, Inc.
Proxy and annual meeting filings cover director elections, auditor ratification, executive compensation votes and amendments to the Concentrix Corporation Amended and Restated 2020 Stock Incentive Plan. Other governance disclosures address board composition and investor-rights provisions associated with the company’s Webhelp acquisition history.
Concentrix Corp director Cheng Chih-Kai filed an initial Form 3, which is the mandatory statement of beneficial ownership for new insiders. The data provided shows no reportable transactions, exercises, gifts, or restructurings, indicating this filing is purely administrative disclosure rather than a trading event.
Concentrix Corp ownership filing: The Vanguard Group amended its Schedule 13G to report 0 shares beneficially owned, representing 0% of the class. The amendment explains an internal realignment effective January 12, 2026, under SEC Release No. 34-39538 that caused certain Vanguard subsidiaries or business divisions to report separately.
The filing is administrative and reports no voting or dispositive power over Concentrix common stock as of the amendment.
Concentrix reported mixed first quarter 2026 results. Revenue rose to $2,500.4 million, up 5.4% year-on-year, but GAAP net income fell to $21.6 million from $70.3 million, with diluted EPS dropping to $0.33 from $1.04.
Non-GAAP diluted EPS declined more modestly to $2.61 from $2.79, and adjusted EBITDA decreased to $348.2 million from $374.2 million. Operating cash flow was a use of $83.2 million and adjusted free cash flow was a use of $144.6 million. The company paid a $0.36 dividend, repurchased about 1 million shares for $42.0 million, and guided to low single-digit constant-currency revenue growth and non-GAAP diluted EPS of $2.57–$2.69 for Q2 and $11.48–$12.07 for full-year 2026, with expected adjusted free cash flow of $630–$650 million.
Concentrix Corporation has amended its accounts receivable securitization facility to expand its borrowing capacity and extend its duration. The lending commitment under the facility increased from up to $700 million to up to $750 million, giving the company more flexibility to fund working capital secured by receivables.
The amendment also pushes the facility’s termination date from January 14, 2027 to March 20, 2028. Concentrix acts as servicer, with Concentrix Receivables, Inc. as borrower and PNC Bank, National Association as administrative agent, alongside other group agents and lenders.
Concentrix Corporation issued and sold $600,000,000 aggregate principal amount of 6.500% Senior Notes due 2029 in a registered public offering. The company used the net proceeds, together with other funds, to redeem $600 million of its 6.650% Senior Notes due August 2, 2026.
The new notes pay 6.500% interest semi-annually starting September 1, 2026 and mature on March 1, 2029. Their interest rate may be adjusted if Moody’s, S&P or Fitch change the notes’ debt rating. The notes are callable, with a make-whole call before February 1, 2029 and par redemption thereafter.
Concentrix Corporation is issuing $600 million of 6.500% Senior Notes due 2029 in a public offering under an effective shelf registration. The company has entered into an underwriting agreement led by BofA Securities and J.P. Morgan, with closing expected on February 24, 2026, subject to customary conditions.
Concentrix expects to use the net proceeds, together with other funds, to redeem or otherwise repay all or a portion of its 6.650% Senior Notes due August 2, 2026 and pay related fees and expenses. It has notified holders that $600 million of the currently outstanding $800 million aggregate principal amount of these 2026 Notes will be redeemed on February 24, 2026.
Concentrix Corporation is asking stockholders to vote at its virtual 2026 annual meeting on March 25, 2026. Holders of 61,287,407 eligible common shares as of January 27, 2026 can attend and vote online.
Stockholders will elect nine directors, ratify Ernst & Young as auditor, cast an advisory say‑on‑pay vote, and decide on an amendment to the 2020 Stock Incentive Plan to increase available shares. The proxy also highlights 2025 results, including about $9.8 billion in revenue, a GAAP net loss of $1.28 billion, non‑GAAP net income of $743.4 million, and returning roughly $258 million to stockholders while reducing net indebtedness by $184 million.
Concentrix Corporation is issuing $600 million of 6.500% senior unsecured notes maturing March 1, 2029. The notes pay semi-annual interest starting September 1, 2026 and the coupon can step up by up to 2.000 percentage points if credit ratings are downgraded.
Concentrix expects net proceeds of about $595.2 million, to be used with other funds to redeem or repay part or all of its outstanding $800 million 6.650% senior notes due August 2, 2026. The new notes are redeemable at Concentrix’s option, include a change-of-control repurchase feature at 101% of principal, are not guaranteed by subsidiaries, and will not be listed on any securities exchange.
AQR Capital Management, LLC and AQR Capital Management Holdings, LLC filed an amended Schedule 13G reporting beneficial ownership of 2,950,287 shares of Concentrix Corp common stock, representing 4.74% of the class as of 12/31/2025. Both entities report no sole voting or dispositive power over the shares, but shared voting and shared dispositive power for the full amount. The firms state the holdings were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Concentrix.